Login / Signup

Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.

Michael A NauckJuris J MeierWolfgang E Schmidt
Published in: Diabetes, obesity & metabolism (2017)
Keyphrases
  • electronic health record
  • big data
  • blood glucose
  • type diabetes
  • machine learning
  • data analysis
  • metabolic syndrome
  • artificial intelligence
  • deep learning